Walgreen's has reported fiscal fourth quarter results, showing continued prescription growth and highlighting its broader wellness and health management efforts.
Read More
Having taken heat on drug safety, the FDA has issued a new draft guidance on risk mitigation efforts by drug companies.
Read More
In another personalized medicine development, researchers at UCLA have identified a way to improve depression treatment.
Read More
A recent drug trial illustrates how comparative effectiveness research may actually facilitate more health care spending.
Read More
Pharmacogenomics is at the forefront of personalized medicine development. Recent research indicates promise in anti-platelet therapy guidance.
Read More
A recent report from NEHI states that medication therapy non-compliance leads to $290 billion in avoidable medical costs every year.
Read More
The physical distribution and payment flows for pharmaceuticals in the United States are very complex. A new report helps explain those processes.
Read More
An article examines barriers to physician participation in medical research.
Read More
The three largest PBMs have issued their second quarter results. All appear to be performing well.
Read More
Between lobbying and price increases, drug manufacturers are doing a good job of protecting their economic interests.
Read More
A study indicates that patients who receive medical care and prescriptions at the worksite tend to be more compliant with their drug regimens.
Read More
The limiting of growth in drug spending is a health care success story.
Read More
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts